The fungus Gibberella fujikuroi is used for the commercial production of gibberellins (GAs), which it produces in very large quantities. Four of the seven GA-biosynthetic genes in this species encode cytochrome P450 monooxygenases, which function in association with NADPH: cytochrome P450 reductases (CPRs) that mediate the transfer of electrons from NADPH to the P450 monooxygenases. Only one cpr gene (cpr-Gf) was found in G. fujikuroi and cloned by a PCR approach. The encoded protein contains the conserved CPR functional domains, including the FAD-, FMN-, and NADPH-binding motifs. cpr-Gf disruption mutants were viable but showed a reduced growth rate. Furthermore, disruption resulted in total loss of GA 3 , GA 4 and GA 7 production, but low levels of non-hydroxylated C 20 -GAs (GA 15 and GA 24 ) were still detected. In addition, the knock-out mutants were much more sensitive to benzoate than the wild-type due to loss of activity of another P450 monooxygenase, the detoxifying enzyme, benzoate p-hydroxylase.
INTRODUCTION
with the heterologous A. niger cprA gene. We have also compared the regulation of cpr-Gf with that of the four GA-biosynthetic monooxygenase genes.
EXPERIMENTAL PROCEDURES
Fungal Strains-Strains IMI58289 (Commonwealth Mycological Institute, Kew, UK) and m567 (Fungal Culture Collection, Weimar, Germany) are GA-producing wild-type strains of G. fujikuroi mating population (MP)-C (anamorph F. fujikuroi). The GA-deficient mutant G. fujikuroi SG138 (kindly provided by J. Avalos, University of Sevilla, Spain) strain was derived from IMI58289 via UV mutagenesis of spores (37) .
Bacterial strains and plasmids-Escherichia coli strain Top10 (Invitrogen, Groningen, The Netherlands) was used for plasmid propagation. Vector pUC19 was used to clone DNA fragments carrying the G. fujikuroi cpr gene and gene fragments. First, a 2.2 kb BglII-fragment of -clone 2-1 was cloned into BamHI-restricted pUCI9 (pCPR1A). Then a 3.8 kb XbaI-fragment was cloned into pUCI9/XbaI (pCPR1B). pCPR1B was cut with NcoI/SphI. The derived 3 kb-fragment was cloned into pCPR1A/NcoI/SphI to produce vector pcpr-Gf, containing the entire cpr-Gf gene. The vector pNR1 was constructed by cloning the PstI/BamHI fragment of the Streptomyces noursei nat1 gene encoding the nourseothricin acetyltransferase (38) , into pBluescript II KS. The gene was transcribed under control of the A. nidulans oliC promoter (39) and terminated by the Botrytis cinerea tub1 terminator (van Kan, personal communication). For gene replacement experiments, fragments from 6 fungal strains were grown in 100%, 20% or 0% ICI medium (42) , containing 8% glucose, 0.5% MgSO 4 , 0.1% KH 2 PO 4 , and 5.0, 1.0 or 0 g/l NH 4 NO 3 , respectively.
For analysis of cpr-Gf expression with and without benzoate, strain IMI58289 was cultivated for three days in 10% ICI medium on a rotary shaker at 28°C. The mycelium was washed and 1.5 g (wet weight) each were transferred to 50 ml of 0% or 100% ICI medium with or without (0.5 mM or 1mM) benzoate. For GA production, the strains were grown for 7-10 days on a rotary shaker (200 rpm) at 28°C in 300-ml Erlenmeyer flasks containing 100 ml of either 20% ICI or optimized production medium (OPM), containing 6% sunflower oil, 0.05% (NH 4 ) 2 SO 4 , 1.5% corn-steep solids (Sigma-Aldrich, Taufkirchen, Germany), and 0.1% KH 2 PO 4 . Benzoate plate tests were performed on CM and Czapek Dox (Sigma-Aldrich) agar with 1 mM benzoate or without benzoate.
DNA and RNA isolation-Genomic DNA was isolated from lyophilized mycelium as described by Doyle and Doyle (43) . Lambda DNA from positive lambda clones was prepared according to Maniatis et al. (44) . Plasmid DNA was extracted using Genomed columns following the manufacturer's protocol (Genomed, Bad Oeynhausen, Germany). RNA was isolated using the RNAgents total RNA isolation kit (Promega, Mannheim, Germany). Southern and Northern blot analysis-After digestion with restriction endonucleases and electrophoresis, genomic or lambda DNA was transferred onto Hybond N + filters (Amersham Pharmacia, Freiburg, Germany). 32 P-labelled probes were prepared using the random oligomerprimer method (44) . Filters were hybridized at 65°C or 56°C in 5 x Denhardt's solution containing 5% dextran sulfate (44) . Filters were washed at the same temperature used for hybridization in 2 x SSPE 0.1% SDS and 1 x SSPE 0.1% SDS.
PCR-Degenerate
Northern blot hybridizations were accomplished by the method of Church and Gilbert (47) . The G. fujikuroi rDNA gene was used as a control hybridization probe to confirm RNA transfer.
Sequencing-DNA sequencing of recombinant plasmid clones was accomplished with an automatic sequencer "LI-COR 4000" (MWG, München, Germany). The two strands of overlapping subclones obtained from the genomic DNA clones were sequenced using the universal and the reverse primers or specific oligonucleotides obtained from MWG Biotech (Munich, Germany). For complementation of the transformant cpr -T20 with the wild-type cpr-Gf gene, protoplasts were co-transformed with 10 g of each the circular complementation vector pcpr-Gf and pNR1.
Transformed protoplasts were regenerated at 28°C on complete regeneration agar (0.7 M sucrose, 0.05 % yeast extract, 0.1 % (NH 4 ) 2 SO 4 ) containing 120 µg/ml hygromycin B (Calbiochem, Bad Soden, Germany) or 100 µg/ml nourseothricin (Werner BioAgents, Jena, Germany) for 6-7 days.
For purification, single conidial cultures were obtained from hygromycin B-or nourseothricinresistant transformants and used for DNA isolation and Southern blot analysis.
Gibberellin assays-GA 3 and GA 4/7 were analyzed by thin layer chromatography on silica gel eluted with ethyl acetate/ chloroform/ acetic acid (60:40:5). The complete GA complement produced by the different strains was determined by GC-MS analysis after extraction from the culture fluid as already described (8) , except that compounds were separated on a 30m x 0.32 mm x 0.25 µm HP-5 WCOT column (Agilent Technologies) and analysed using a MAT95XP mass spectrometer (Thermo Electron Corporation) GC-MS conditions were as described previously (8) .
Compounds were identified by comparison of their mass spectra with those in a spectral library (49) . For quantitative analysis of GAs aliquots of the extracts were spiked with [17-2 H 2 ]GA internal standards and analyzing using a GCQ instrument (Thermo Electron Corporation) as described previously (50), except chromatogram peak areas were obtained from full scans.
Plate tests with benzoate-For analysis of benzoate tolerance, strains IMI58289, SG138 and transformants T20 and KT-1 were grown for 6 d at 28°C on CM and CD agar containing 1 mM benzoate. The deletion of the wild-type copy of cpr in transformants T20 and T49 was confirmed by
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Northern blot analysis. The wild-type, transformant T57 and mutant SG138 contain a transcript of about 2.1 kb, whereas T20 and T49 have lost the entire coding region of cpr and do not show any cpr transcript (Fig. 3B ).
GA production and growth characteristics of deletion mutants and strain SG138-In order to
determine the effect of cpr-Gf deletion on GA production, the wild-type strain, both knock-out mutants and the putative cpr mutant SG138 were cultivated for 7 days in the synthetic 20% ICI medium. The culture fluids were then analyzed by TLC (Fig. 3C ) and GC-MS (Table I) .
Transformants T20 and T49 as well as mutant SG138 do not produce GA 4 , GA 7 and GA 3 , the last three products of the pathway. Interestingly, the deletion mutants and SG138 show a reduction of growth rate on agar plates, which is more significant on minimal CD agar (Fig. 4C ) than on CM medium (Fig. 4A) . The similar characteristics for T20, T49 (data not shown) and SG138 as well as the described loss of P450-catalyzed oxidation steps (37) support our proposal that the latter strain is also affected in cpr-Gf.
Identification of the mutation in SG138-To confirm our proposal that the UV treatment affected the cpr gene in the mutant SG138, the cpr gene from the mutant was amplified by four primer pairs to give four overlapping fragments, which were cloned and three independent clones were sequenced in both directions. Comparison with the sequence of the wild-type gene copy confirmed a point mutation in the first position of the codon at aa position 627 from C to T resulting in a TGA stop codon instead of CGA for arginine. The truncated CPR peptide is therefore 83 aa shorter than the wild-type CPR enzyme. All CPR proteins analyzed so far contain a NADPH binding domain consisting of three segments (32) . This is also the case for CPR-Gf (Fig. 1A) . In the mutant SG138 a large part of the last segment of the NADPH binding domain is missing.
Complementation of a deletion mutant with the wild-type cpr-Gf gene-The deletion mutant T20
was co-transformed with the complementation vector pcpr-Gf carrying the wild-type cpr-Gf gene, and vector pNR1 with the nourseothricin resistance gene as selection marker (see Experimental procedures). Two nourseothricin-resistant transformants, KT-1 and KT-13, were analyzed for correct integration of the cpr-Gf gene. As shown in Southern blot (data not shown) and Northern blot analysis (Fig. 5) , only KT-1 showed multiple copies of the hybridizing wild-type gene and a high transcript level of the correct size, whereas transformant KT-13 does not contain vector pcprGf. Analysis of the GA concentrations showed almost full restoration of GA production. Analysis of the three final products, GA 4 , GA 7 and GA 3 , by GC-MS (Table I ) demonstrated that the activity of all four P450 monooxygenases was at least partially restored resulting in production of the normal GA pattern (Fig. 6 ) and formation of wild-type-like amounts (or even more) of the final product gibberellic acid (GA 3 ). Furthermore, the growth rate of KT-1 on CM and CD agar was comparable to that of the wild-type (Fig. 4A, 4C ).
Analysis of GA intermediates in the cpr mutants-The effect of cpr-Gf-deletion on each of the P450-catalyzed steps in the GA-biosynthetic pathway was investigated by determining the full spectrum of intermediates in the cpr mutants (Fig. 6 ) and quantifying selected intermediates by GC-MS (Table I ). The cpr deletion mutants do not produce GA 3 , GA 4 or GA 7 , the final products of the GA-biosynthetic pathway, but only a very low amount of the non-hydroxylated intermediates GA 15 and GA 24 together with high levels of ent-kaurene (Fig. 7) . The level of GAs in cpr is about 1% of that found in the wild-type strain IMI58289. These results indicate a very low activity of ent-kaurene oxidase (P450-4) and low but significant activities for GA 7-oxidase (one of the activities of P450-1) and GA 20-oxidase (P450-2) in the absence of the P450 reductase. In contrast, 3 -hydroxylation,
another activity of the P450-1 monooxygenase, was absent in cpr and thus would appear to have an absolute requirement for the P450 reductase. The spectrum of GAs found in SG138 (Table I) was similar to that in cpr, consistent with our demonstration of a mutation in the P450 reductase in this strain. The GA profile and amounts in cpr and SG138 were restored to those in the wild-type strain by complementation with the reductase gene from G. fujikuroi (Table I and Fig. 6 ). The major products synthesized by the complementation mutants were the 3 -hydroxylated GAs GA 3 and GA 1 plus lower amounts of GA 4 and GA 7 . Interestingly, the GA-producing ability of SG138 was also fully restored by complementation with the reductase gene from Aspergillus niger (cpr-A, see below)
although A. niger is not able to produce any GAs (Table I) .
The specificity of cpr-Gf for GA biosynthesis activity-As part of an enquiry into whether or not cpr-Gf is specific for the P450s involved in GA biosynthesis we investigated if the cpr and GA monooxygenase genes were co-regulated. Co-regulation has been reported, for example, for the A.
niger cprA and benzoate p-hydroxylase (bphA) genes (14) .
Three of the four GA-specific P450 monooxygenase genes (P450-1, P450-2 and P450-4) are known to be regulated by the general transcription factor AREA (51) and thus are highly expressed under nitrogen starvation conditions. Therefore, we compared the expression pattern of these three P450 genes with that of cpr-Gf. Interestingly, the cpr-Gf gene is co-regulated with P450-1, P450-2
and P450-4: high cpr-Gf transcription levels were found under nitrogen starvation conditions, but much less (though higher than for the monooxygenase genes) with high amounts of nitrogen (Fig.   8A ). We investigated the specificity of the interaction between CPR-Gf and the GA-biosynthetic monooxygenases by transforming the mutant SG138 with the cprA gene of A. niger. Ten hygromycin-resistant transformants were cultivated under GA production conditions and analyzed for GA content. Three transformants, SG138-cprA-7, -8, and -19, were able to produce GA 3 (e.g SG138-cprA-7, Table I ), demonstrating that CPRA from the GA-non-producing fungal species A.
niger which is described as activator of the benzoate p-hydroxylase, is able to act as electron donor and activator of GA-biosynthetic enzymes P450-1 to P450-4 in G. fujikuroi. However, in contrast to cpr-Gf, cprA was expressed independently of nitrogen condition in G. fujikuroi (Fig. 8B ).
On the basis of these results, we speculated that CPR-Gf may also act in much more than the GA-biosynthetic pathways. In order to show this, we determined if CPR-Gf is involved in detoxification of benzoate in a similar way to CPRA in A. niger. We grew the wild-type strain IMI58289, two cpr-Gf mutants, SG138 and T20, as well as the complemented strain KT-1 on CM and CD agar with or without benzoate. The growth patterns show very clearly that mutation or deletion of cpr-Gf led to an extreme sensitivity to this compound due to the lost activation of the benzoate p-hydroxylase by CPR-Gf. On the other hand, complementation of T20 with the wild-type cpr-Gf copy fully restored the high resistance level for benzoate (Fig. 4B,D) .
These results led us to anticipate induction of cpr-Gf gene expression by benzoate, as is the case for cprA in A. niger. Addition of benzoate to the medium significantly induced the cpr-Gf transcription level in G. fujikuroi, especially when 1mM benzoate was added (Fig. 9 ). Interestingly, with benzoate in the medium, cpr-Gf expression is no longer repressed by high amounts of nitrogen.
DISCUSSION
Using degenerate PCR and genomic library screening we isolated a gene from G. fujikuroi with high homology with cytochrome P450 reductase (CPR) genes from other species, particularly the gene from A. niger (cprA) with which it is 61% identical at the amino acid level. The G. fujikuroi cpr gene (cpr-Gf) encodes a protein of 713 amino acids containing all expected domains for binding the prosthetic factors FAD, FMN and NADPH as well as for P450s (32) . Targeted disruption of cpr-Gf led to a very substantial loss of GA production demonstrating that the reductase is required for normal activity of P450s involved in GA-biosynthesis. In G. fujikuroi GA biosynthesis requires four P450 monooxygenases, which are responsible for more than 10 enzymatic steps. P450-4 catalyzes the three oxidation steps from ent-kaurene to ent-kaurenoic acid (5). P450-1 catalyzes the oxidation of ent-kaurenoic acid to ent-7 -hydroxykaurenoic acid, followed by ring contraction with the production of GA 12 -aldehyde, its 3ß-hydroxylation to GA 14 -aldehyde, and oxidation to GA 14 , in addition to several side reactions (6). P450-2 converts GA 14 to GA 4 and GA 12 to GA 9 with the loss of carbon-20 (7). Finally, P450-3 is responsible for the 13-hydroxylation of GA 7 to GA 3 , and, in a minor pathway, of GA 4 to GA 1 (8) . Although not all P450-catalyzed steps are completely blocked in the deletion mutants, they are reduced in activity and some reactions, such as 3ß-hydroxylation and loss of C-20, are completely absent in cpr mutants.
Thus, CPR-Gf may act as electron donor of all four P450 monooxygenases.
The small amounts of the non-hydroxylated GA 15 and GA 24 , and the high level of ent- Beside the dramatic effect on GA production, mutations in cpr in the deletion mutants and SG138 affected also the growth rate on synthetic medium and to a lesser extend on CM medium indicating that CPR probably acts as electron donor also for P450-related pathways in primary metabolism, e.g. for metabolism of sterols and fatty acids. However, the effect on primary metabolism, especially on CM medium, is not as strong as might be expected if CPR-Gf were the only electron donor associated with P450s in G. fujikuroi. It is also possible that the reduced growth rate is due to the accumulation of toxic intermediates of disrupted secondary metabolite pathways.
Although A. niger does not produce GAs and does not contain GA-related P450s, the cprA gene, Therefore, it is likely that G. fujikuroi contains a single cpr gene that interacts with each of the P450s.
We analyzed the GA-biosynthetic and cpr genes also in the closest related members of the G.
fujikuroi species complex consisting of eight mating populations (MP-A to MP-H). Most of these species contain the complete GA gene cluster, but only members of MP-C (F. fujikuroi) are able to produce GAs. The loss of GA production capability is due to a set of mutations in the coding and 5´-noncoding regions of the GA-biosynthetic genes resulting in an overall amino acid sequence identity of only 84-94% in the case of P450-4. In contrast to the dispensable GA pathway genes, the level of sequence identity between the CPR enzymes is about 98% (Malonek and Tudzynski, unpublished results). These results suggest the importance of CPR for essential functions of cell metabolism.
Here we report on the first deletion of a cpr gene in a filamentous fungus. So far, only in S.
cerevisiae has the single cpr gene been successfully deleted without dramatic influence on viability (54) , indicating that an alternative electron donor must exist. It was suggested that in S. cerevisiae, a cytochrome b5 (cyt b5) could act as a second important element in the electron donating system.
Deletion of cyt b5 in the wild-type did not display a phenotype, whereas disruption of the gene in a cpr strain was lethal demonstrating that both enzymes can complement each other in mutants with single disruptions of cpr or b5 (54) . However, there is no additional electron donating system overcoming the double knock out. In G. fujikuroi, the GA-biosynthetic pathway is under control of nitrogen metabolite repression.
Nitrogen starvation results in a many-fold increase in transcript level for three of the four P450s monooxygenase genes not fused to cpr genes. Our results indicate that cpr-Gf, which is not located in the GA gene cluster, encodes the main electron donor responsible not only for activation of all four GA-related P450 monooxygenases, but also for benzoate p-hydroxylase and at least some P450s involved in primary metabolism. Cloning and characterization of the gene encoding the G.
fujikuroi cytochrome b5 might provide insights into the possible role of this enzyme as an alternative electron donator and its participation in the functional complex of GA P450s. data (65) as follows: peak 1, ent-kaurene; peak 2, ent-kaurenoic acid; peak 3, GA 9; peak 4, GA 25 ; peak 5, GA 24 ; peak 6, GA 14 and 7 -hydroxykaurenolide; peak 7, GA 4 ; peak 8, GA 7 ; peak 9, fujenoic acid, peak 10 GA 13 ; peak 11, GA 36 ; peak 12; GA 3 isolactone; peak 13, 7 , 18-dihydroxykaurenolide; peak 14, GA 1 ; peak 15, GA 3 ; peak 16, entkaurenol; peak 17, GA 15 . Unlabeled peaks are due to compounds unrelated to GA biosynthesis. The peak at the same retention time as ent-kaurene in the KT-1 extract contains no ent-kaurene. Northern blot analysis of the wild-type IMI58289 showing benzoate induction of cpr gene expression. The strain was cultivated for three days in 10% ICI and then transferred to 0% or 100% ICI medium with 0.5mM, 1mM or without benzoate.
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